RFK Jr.’s Plans to Change Childhood Vaccines

Last updated 6 days ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

The United States is undergoing significant changes in public health policy under the Trump administration. After Robert F. Kennedy Jr. was confirmed as Secretary of Health and Human Services, the federal government has initiated a sweeping review of the childhood vaccination schedule.

This initiative, called “Make America Healthy Again” (MAHA), represents a fundamental shift from collective herd immunity toward what they call “medical freedom,” “individual decision-making,” and “radical transparency” about vaccine safety and ingredients.

The administration has proposed or is considering major changes to the standard pediatric vaccine schedule, including delaying the Hepatitis B birth dose, breaking up combination vaccines like the MMR (measles, mumps, rubella), and re-evaluating the safety of ingredients like aluminum.

These proposals challenge decades of scientific consensus in American pediatrics. HHS officials argue these changes address what they call a “chronic disease epidemic” linked to the vaccine schedule. Medical organizations including the American Academy of Pediatrics and Infectious Diseases Society of America say reducing vaccination rates will increase preventable diseases.

The “Make America Healthy Again” Philosophy

The proposed changes to childhood shots stem from a shift in how HHS views public health priorities. The Department of Health and Human Services has moved away from the traditional “infectious disease control” model toward a model focused on “chronic disease elimination” and “toxic load reduction.”

The Chronic Disease Theory

Kennedy’s health policy centers on his belief that the United States faces a chronic disease crisis that’s worse than any threat from infectious disease. HHS literature released in late 2025 cites alarming statistics: “6 in 10 Americans have at least one chronic disease,” “1 in 4 American children suffer from allergies,” and autism rates have risen to “1 in 31.”

Secretary Kennedy and his team view the childhood immunization schedule as a primary environmental cause of this crisis. The administration’s rhetoric frequently links the “drastic rise in chronic disease”, specifically autoimmune disorders, food allergies, and conditions like autism and ADHD, to what they call the “exploding vaccine schedule.”

The theory suggests that while individual vaccines may be safe alone, giving multiple shots with ingredients like aluminum to infants with developing brains creates a “toxic load” that triggers chronic health problems.

The MAHA agenda aims to “reform America’s food, health, and scientific systems to identify the root causes” of this epidemic. This involves a skeptical re-examination of “gold-standard science,” with officials suggesting that previous regulatory bodies acted as “rubber stamps” for the pharmaceutical industry rather than impartial guardians of public safety.

“Informed Consent” Over Mandates

The practical mechanism for this shift is replacing blanket public health mandates with “individual-based decision-making.” In September 2025, Deputy Secretary of HHS Jim O’Neill declared, “Informed consent is back,” signaling an end to the coercive mandates that characterized the COVID-19 pandemic response.

This framework treats vaccination as a personal medical decision rather than a civic duty for community protection. Each family weighs the risks and benefits.

The administration argues that parents have been “coerced” into a one-size-fits-all schedule that doesn’t account for individual biological vulnerabilities. By emphasizing “transparency” about potential side effects, HHS aims to empower parents to opt out of specific shots without facing state-level pressure or social stigma.

This shift is codified in new guidance that encourages “shared clinical decision-making” for vaccines previously recommended routinely. The administration frames this as restoring the doctor-patient relationship, while critics argue it essentially privatizes public health, leaving the most vulnerable unprotected.

Who’s Making These Decisions Now?

The proposals to change the vaccine schedule reflect deliberate restructuring of federal advisory bodies. The personnel changes throughout 2025 have fundamentally altered how scientific evidence is evaluated at the federal level.

Changes to ACIP Membership

The Advisory Committee on Immunization Practices (ACIP) has historically been the “Supreme Court” of American vaccination, a body of independent experts that reviews safety and efficacy data to set the standard of care.

In a move described by medical historians as unprecedented, Secretary Kennedy made a “clean sweep” of the committee in summer 2025, removing all 17 sitting members.

The administration justified this purge by citing a need to eliminate conflicts of interest and “foster a culture of critical inquiry.” The dismissed members were replaced by a new slate of appointees vetted for their willingness to challenge established pharmaceutical norms and their alignment with the MAHA philosophy.

Key New Appointees:

Martin Kulldorff: Biostatistician and co-author of the Great Barrington Declaration; vocal critic of COVID-19 lockdowns and mandates; served as ACIP chair from June-December 2025 before moving to a senior HHS strategy role on December 1, 2025.

Dr. Kirk Milhoan (Current Chair as of December 1, 2025): Pediatric Cardiologist who has publicly claimed COVID-19 vaccines are “contaminated” with “naked DNA” that causes cancer and linked vaccines to miscarriage rates.

Dr. Jay Bhattacharya: Health policy expert appointed to lead the revived Task Force on Safer Childhood Vaccines; advocate for focused protection rather than universal mandates.

This shift has transformed the ACIP from a body that typically validates CDC consensus into an active engine of skepticism. The new committee has already demonstrated its influence by delaying votes on the Hepatitis B schedule and reversing the recommendation for the combined MMRV vaccine.

The Task Force Revival

In August 2025, HHS announced the reinstatement of the “Task Force on Safer Childhood Vaccines,” a federal panel that had been disbanded in 1998.

This revival is both symbolic and practical. By tasking this body with developing vaccines that result in “fewer and less serious adverse reactions,” the federal government is implicitly admitting that the current vaccine supply isn’t sufficiently safe, a core narrative of the vaccine-skeptic movement.

The Task Force, chaired by NIH Director Jay Bhattacharya, is charged with improving adverse reaction reporting systems (like VAERS) and overseeing the “continuous improvement” of vaccine safety. This move has been praised by groups like Children’s Health Defense as long overdue, while pediatric organizations worry it will generate official reports that exaggerate minor risks and fuel vaccine hesitancy.

The Hepatitis B Debate

The most immediate and contentious proposal facing the ACIP in December 2025 is the revision of the Hepatitis B vaccination schedule. Since 1991, the United States has recommended a “birth dose” of the Hepatitis B vaccine for all medically stable infants within 24 hours of birth, regardless of the mother’s infection status.

This policy is credited with virtually eliminating Hepatitis B infection in American children. The new administration is seeking to dismantle this universal recommendation in favor of a targeted approach.

What They’re Proposing

The proposal involves a fundamental change to the “birth dose” protocol:

Universal Maternal Screening: The administration proposes mandating rigorous Hepatitis B screening for all pregnant women to identify those who are infected.

Targeted Delay: For infants born to mothers who test negative, the first dose of the vaccine would be delayed.

Proposed Timelines: Various proposals range from giving the first shot at one month of age to waiting until the child is 12 years old or entering adolescence.

Why They Want to Change It

Proponents view Hepatitis B primarily as a lifestyle-associated disease transmitted through sexual contact or shared needles. They argue that an infant born to a non-infected mother in a typical household has virtually zero risk of contracting the disease during childhood.

Proponents argue that vaccinating a newborn against a disease they’re unlikely to encounter for over a decade imposes an unnecessary burden. “Why inject a newborn with aluminum for a sexually transmitted disease?” is a common refrain among the new HHS leadership.

They argue that maternal screening is now advanced enough to catch infected mothers, allowing for targeted vaccination of high-risk infants while sparing the vast majority of low-risk infants from early exposure to vaccine ingredients.

Why Doctors Say This Is Dangerous

Public health experts, liver specialists, and pediatricians strongly oppose the change. Their opposition isn’t based on denying how the disease spreads, but on the unique devastation Hepatitis B wreaks on infant livers.

The Biology of Infant Infection

The primary reason for the birth dose isn’t the probability of infection, but the consequence of infection at a young age.

Adults vs. Infants: When a healthy adult contracts Hepatitis B, there’s roughly a 95% chance their mature immune system will clear the virus and develop lifelong immunity. However, when an infant or young child contracts Hepatitis B, their immature immune system often fails to recognize the virus as a threat. Consequently, there’s a 90% chance the infection will become chronic (lifelong).

Silent Killer: These chronic infant infections are typically symptomless for decades. However, the virus quietly damages the liver, leading to significantly elevated risk of cirrhosis, liver failure, and liver cancer in young adulthood. Before the 1991 universal recommendation, liver cancer was a measurable cause of death in American children; today, it’s been virtually eliminated in vaccinated children.

The Problem with Screening

The United States used the strategy currently being proposed, screening mothers and vaccinating only high-risk infants, before 1991. It was abandoned because it failed to stop transmission.

Testing Errors: Maternal screening isn’t perfect. Tests can yield false negatives, results can be lost between the prenatal clinic and the delivery room, or errors can occur in medical records. A 2013-2014 CDC review found that fewer than half of expected births to infected mothers were correctly identified by surveillance.

Household Transmission: Infants can contract Hepatitis B from household contacts other than the mother (fathers, siblings, relatives, caregivers) through microscopic blood exposures (sharing toothbrushes, open sores, accidental scratches). The virus is highly durable and can survive on environmental surfaces for up to a week. A negative mother doesn’t guarantee a Hepatitis-free environment.

The Safety Net: The birth dose acts as a critical safety net. If a mother is infected but the test is missed or incorrect, the vaccine provided within 24 hours acts as post-exposure protection, preventing the 90% risk of chronic infection. Delaying even to one month leaves a 30-day window of extreme vulnerability.

What the Evidence Says

In anticipation of the December 2025 vote, the Vaccine Integrity Project at the University of Minnesota conducted a massive independent review of over 400 studies spanning 40 years.

Released on December 2, 2025, this review found “no evidence to support delaying the birth dose.”

The review concluded that the birth dose is safe and that reverting to a delayed schedule would result in:

• At least 1,400 additional chronic infections annually
• 300 excess cases of liver cancer
• 480 preventable deaths
• Over $222 million in excess healthcare costs

Breaking Up Combination Vaccines

Beyond changing the timing of vaccines, HHS is targeting how vaccines are formulated. A major part of the 2025 agenda is the proposal to “break up” combination vaccines into single-disease shots. The primary focus is the Measles-Mumps-Rubella (MMR) and Measles-Mumps-Rubella-Varicella (MMRV) vaccines.

The Proposal

HHS leadership, including Deputy Secretary Jim O’Neill and endorsed by President Trump via social media, has called on pharmaceutical manufacturers to produce single-disease vaccines for measles, mumps, and rubella. The proposal suggests parents should space these shots out over time rather than giving them together.

Additionally, in September 2025, the ACIP voted to withdraw the recommendation for the combined MMRV vaccine (ProQuad) for children under 4. The new guidance recommends that toddlers receive separate MMR and Varicella (chickenpox) shots rather than the single combined injection.

Why They Want This

Febrile Seizures (MMRV): The move to split MMRV back into MMR + Varicella is based on established safety data. Studies have shown that the combined MMRV shot carries a slightly higher risk of febrile seizures (seizures caused by fever) in toddlers compared to giving MMR and Varicella separately. The risk is approximately 1 additional seizure per 2,300 to 2,600 children vaccinated.

While febrile seizures are generally harmless and leave no lasting damage, the administration frames this as an “unintended side effect” that informed consent should avoid.

The “Too Many Too Soon” Theory (MMR): The broader push to split the MMR itself into three separate shots is based on the theory that “cocktail” vaccines overwhelm a child’s immune system. By spacing out the shots, the administration argues, the “toxic load” is reduced and parents can monitor for reactions to specific agents.

The Reality: It’s Not Possible

The MMRV split has scientific support. The proposal to split MMR into three separate vaccines faces insurmountable problems.

The Vaccines Don’t Exist

Currently, no single measles, mumps, or rubella vaccines are licensed or available in the United States. Merck, the sole manufacturer, discontinued the single-disease versions in 2009 to focus on the more efficient MMR combination.

Timeline to Production: Merck has stated that reintroducing separate vaccines would essentially require treating them as new products. This would involve developing new manufacturing lines, conducting new clinical trials, and securing FDA approval. Merck estimates this would take more than 10 years.

The Problem for Parents: The administration is demanding products that don’t exist. This leaves parents skeptical of the combined MMR with no option for measles protection during a period of rising outbreaks.

More Shots, Fewer Kids Protected

Splitting the MMR into three shots (and MMRV into four) would drastically increase the number of injections a child receives.

Injection Fatigue: If the logic of “unbundling” were applied to the entire schedule (DTaP, MMR, HepB, Hib, Polio), a child would require up to 20 separate visits or injections to become fully vaccinated by age two.

Compliance Drop: Public health experts warn that increasing the burden on parents—more time off work, more co-pays, more trauma for the child—will inevitably lead to missed doses. “The more visits… the less likely to complete all the additional appointments,” notes Yale epidemiologist Jason Schwartz.

Effectiveness Concerns: Historical data from Japan serves as a cautionary tale. When Japan used single mumps vaccines, studies found significantly lower protection rates compared to the combined MMR used elsewhere. The combined vaccine appears to create a better immune response than single shots.

The Aluminum and Mercury Questions

A central part of RFK Jr.’s career—and now his HHS agenda—is scrutiny of vaccine ingredients, specifically adjuvants (substances added to boost immune response) and preservatives.

The Aluminum Review

Aluminum salts (like aluminum hydroxide) are used in many vaccines (such as DTaP, Pneumococcal, and Hepatitis B) to ensure the immune system notices the antigen and creates antibodies. Without aluminum, these vaccines would be largely ineffective.

Secretary Kennedy has long claimed that injected aluminum is neurotoxic and contributes to autism, allergies, and autoimmune disease.

The Federal Review: In late 2025, HHS ordered a full ACIP review of “adjuvants and contaminants,” with a specific focus on aluminum.

The Data Conflict: This review coincides with publication of a massive study from Denmark in July 2025. This nationwide study followed 1.2 million children over 24 years and analyzed their cumulative aluminum exposure from vaccines. The study found no association between aluminum in vaccines and autism, asthma, or autoimmune conditions.

The Political Response: Rather than accepting these findings, Secretary Kennedy publicly denounced the study as a “deceitful propaganda stunt” and demanded its retraction. The publishing journal refused. This incident illustrates the widening gulf between HHS political leadership and the academic scientific community.

Mercury (Thimerosal) in Flu Shots

Thimerosal, a mercury-containing preservative, was removed from all standard childhood vaccines in 2001. However, it remains in multi-dose vials of the influenza vaccine to prevent bacterial growth.

While the CDC has long maintained that the type of mercury in thimerosal (ethylmercury) is cleared rapidly by the body and is safe, it remains a focal point for vaccine skeptics.

In July 2025, the ACIP adopted a new recommendation to use only thimerosal-free (single-dose) flu vaccines for children under 18 and pregnant women. This effectively removes the last trace of thimerosal from the pediatric schedule.

While arguably symbolic—since thimerosal-free options have been available for years—it formally aligns federal policy with the goal of “zero mercury” exposure.

COVID-19 Vaccines for Kids

By late 2025, the federal approach to COVID-19 vaccination for children has shifted from a public health imperative to a strongly cautioned “individual choice,” heavily influenced by new safety claims from the FDA.

“Informed Consent is Back”

In September 2025, the CDC officially updated its immunization schedules to apply “individual-based decision-making” for COVID-19 shots for all individuals, including children. This replaced the previous “blanket recommendation” that all children over 6 months be vaccinated.

Risk Stratification: The new guidance emphasizes that the benefit is distinct primarily for those over 65 or with underlying conditions. For healthy children, the government no longer explicitly recommends the shot.

The Controversial FDA Memo

A flashpoint occurred in November 2025, when Dr. Vinay Prasad, the new Director of the FDA’s Center for Biologics Evaluation and Research, issued an internal memo claiming that a review linked the COVID-19 vaccine to the deaths of “at least 10 children.”

The Claim: Prasad asserted these deaths were caused by vaccine-induced myocarditis (heart inflammation). He described this as a “profound revelation” that the FDA would “acknowledge that Covid-19 vaccines have killed American children.”

The Scientific Pushback: The memo was immediately criticized by external experts like Dr. Paul Offit and Dr. Peter Marks for “science by press release.” Critics noted that VAERS reports are unverified raw data and don’t prove causation. They also emphasized that while vaccine-induced myocarditis is a known rare side effect, it’s typically mild, whereas myocarditis caused by COVID-19 infection is far more common and severe.

New Approval Standards

Under Dr. Prasad and Commissioner Makary, the FDA has announced drastically stricter standards for future vaccine approvals.

Randomized Controlled Trials: The FDA will now demand large-scale RCTs for all new vaccines, including in pregnant women, rejecting “immunobridging” (measuring antibody levels) as a proxy for effectiveness.

Impact: Industry insiders warn this could freeze vaccine innovation. Once a standard-of-care vaccine exists, it’s often unethical to conduct a placebo-controlled trial (leaving the control group unprotected). By demanding such trials, the FDA may effectively halt development of updated boosters or new vaccines for existing diseases.

Some experts have called the new standards “impossible” and warned they could curtail access to immunizations.

What’s Happening at the State Level

The changes at the federal level are triggering shifts in state policy and public behavior, leading to measurable declines in immunization coverage and the re-emergence of disease.

States Dropping Mandates

States aligned with the “medical freedom” agenda are moving to dismantle school entry requirements.

Florida: In September 2025, the Florida Department of Health announced plans to make vaccines for Hepatitis B, chickenpox, Hib, and pneumococcal disease voluntary for school attendance. While mandates for polio and measles currently remain, officials have suggested a desire to end all mandates, equating them to “slavery.”

Idaho: Idaho has seen its non-medical exemption rate skyrocket to 15.1%, the highest in the nation. This level of refusal guarantees that herd immunity is lost in many school districts.

Declining Coverage, Rising Outbreaks

The cumulative effect of mixed messaging, reduced access, and removal of mandates is a statistical decline in protection.

Exemption Rates: The national non-medical exemption rate for kindergartners rose to an all-time high of 3.6% in the 2024-2025 school year. In 17 states, the exemption rate now exceeds 5%, the threshold usually required to maintain herd immunity for measles.

Coverage Gaps: National MMR coverage has fallen to 92.5%, significantly below the 95% threshold required to prevent measles outbreaks.

Disease Resurgence: The US is experiencing its worst year for measles since elimination was declared in 2000, with over 1,333 confirmed cases and 3 deaths in 2025 alone.

The Economic and Social Impact

The proposed overhaul carries profound implications beyond immediate health risks.

The Cost of Disease

If the Hepatitis B birth dose is delayed, the Vaccine Integrity Project estimates an annual cost of $222 million in excess healthcare spending due to treating chronic liver disease and cancer.

Similarly, the cost of managing measles outbreaks—which involve contact tracing, quarantine, and hospitalization—is enormous. A single measles case can cost the public health system over $140,000 to contain.

The Cost of “Unbundling”

The proposal to split combination vaccines imposes a direct cost on parents’ time and resources. Breaking the MMR and MMRV into separate shots would require additional copays for each visit and significantly more time away from work.

This effectively creates a two-tier system where wealthier families might navigate the complex logistics of a “spaced-out” schedule, while working-class families may simply fall behind, leaving their children under-vaccinated by default.

The Erosion of Trust

Perhaps the most lasting impact of the 2025 shift is the erosion of trust in centralized medical authority. By institutionalizing skepticism within HHS and FDA, the government is validating the narrative that “medical freedom” is superior to “public health consensus.”

While this aligns with the MAHA goal of individual empowerment, it fundamentally weakens the nation’s ability to respond to future pandemics or biological threats.

The public is being trained to view CDC recommendations not as the gold standard of safety, but as one opinion among many in a marketplace of medical ideas, a marketplace where the loudest voice, rather than the strongest data, often prevails.

Bottom Line

The 2025 changes to childhood vaccination policy represent a fundamental philosophical shift in American public health. The “Make America Healthy Again” agenda prioritizes individual choice and skepticism of pharmaceutical products over collective disease prevention.

The administration argues these changes address a chronic disease epidemic and restore parental rights. The scientific and medical communities warn they invite the return of preventable infectious diseases.

The early evidence supports the warnings: vaccination rates are falling, exemptions are rising, and measles is surging. The proposed delay of the Hepatitis B birth dose could lead to 1,400 additional chronic infections and hundreds of preventable deaths annually.

The push to split combination vaccines faces practical impossibilities—the single-disease vaccines don’t exist and would take a decade to produce. Meanwhile, the new ACIP leadership includes members who have promoted debunked claims about vaccine contamination and cancer.

As vaccination requirements change at state and federal levels, public health officials are monitoring impacts on disease rates and vaccine coverage.

The results are already measurable in falling vaccination rates and rising disease outbreaks. The long-term consequences—for children’s health, healthcare costs, and America’s ability to respond to future threats—remain to be seen.

Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.